flecainide has been researched along with Equine Diseases in 6 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "OBJECTIVE To compare the efficacy of quinidine and flecainide in treating naturally occurring, recent-onset atrial fibrillation (AF) in Thoroughbred racehorses." | 7.88 | Treatment of recent-onset atrial fibrillation with quinidine and flecainide in Thoroughbred racehorses: 107 cases (1987-2014). ( Ishikawa, Y; Ohmura, H; Takahashi, Y, 2018) |
| " flecainide has a high efficacy for the treatment of experimentally-induced acute atrial fibrillation (AF) in horses and that its use is associated with minimal toxic side effects." | 7.72 | Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. ( Blissitt, KJ; Keen, JA; van Loon, G; Young, LE, 2004) |
| "To determine a safe and efficacious dose of flecainide acetate for treating equine atrial fibrillation (Af), the safe dosage level was determined by injecting 1, 2, or 3 mg/kg i." | 7.70 | Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation. ( Amada, A; Mizuno, Y; Nakayama, T; Nukada, T; Ohmura, H; Yamaya, Y, 2000) |
| "Flecainide has been tested with variable efficacy." | 6.87 | Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses. ( Buhl, R; Carstensen, H; Fenner, M; Flethøj, M; Hesselkilde, EZ; Jespersen, T; Kanters, JK; Loft-Andersen, AV; Pehrson, S; Sattler, SM; Tfelt-Hansen, J, 2018) |
| "OBJECTIVE To compare the efficacy of quinidine and flecainide in treating naturally occurring, recent-onset atrial fibrillation (AF) in Thoroughbred racehorses." | 3.88 | Treatment of recent-onset atrial fibrillation with quinidine and flecainide in Thoroughbred racehorses: 107 cases (1987-2014). ( Ishikawa, Y; Ohmura, H; Takahashi, Y, 2018) |
| " flecainide has a high efficacy for the treatment of experimentally-induced acute atrial fibrillation (AF) in horses and that its use is associated with minimal toxic side effects." | 3.72 | Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation. ( Blissitt, KJ; Keen, JA; van Loon, G; Young, LE, 2004) |
| "To determine a safe and efficacious dose of flecainide acetate for treating equine atrial fibrillation (Af), the safe dosage level was determined by injecting 1, 2, or 3 mg/kg i." | 3.70 | Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation. ( Amada, A; Mizuno, Y; Nakayama, T; Nukada, T; Ohmura, H; Yamaya, Y, 2000) |
| "Flecainide has been tested with variable efficacy." | 2.87 | Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses. ( Buhl, R; Carstensen, H; Fenner, M; Flethøj, M; Hesselkilde, EZ; Jespersen, T; Kanters, JK; Loft-Andersen, AV; Pehrson, S; Sattler, SM; Tfelt-Hansen, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, Y | 1 |
| Ishikawa, Y | 1 |
| Ohmura, H | 2 |
| Carstensen, H | 2 |
| Hesselkilde, EZ | 2 |
| Fenner, M | 1 |
| Loft-Andersen, AV | 1 |
| Flethøj, M | 2 |
| Kanters, JK | 1 |
| Sattler, SM | 1 |
| Tfelt-Hansen, J | 1 |
| Pehrson, S | 2 |
| Jespersen, T | 2 |
| Buhl, R | 2 |
| Haugaard, MM | 1 |
| Praestegaard, KF | 1 |
| Diness, JG | 1 |
| Grunnet, M | 1 |
| van Loon, G | 1 |
| Blissitt, KJ | 1 |
| Keen, JA | 1 |
| Young, LE | 1 |
| Birettoni, F | 1 |
| Porciello, F | 1 |
| Rishniw, M | 1 |
| della Rocca, G | 1 |
| Di Salvo, A | 1 |
| Sgorbini, M | 1 |
| Nukada, T | 1 |
| Mizuno, Y | 1 |
| Yamaya, Y | 1 |
| Nakayama, T | 1 |
| Amada, A | 1 |
3 trials available for flecainide and Equine Diseases
| Article | Year |
|---|---|
Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Horse Diseases; Horses; Pa | 2018 |
Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Flecainide | 2015 |
Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation.
Topics: Animals; Anti-Arrhythmia Agents; Area Under Curve; Atrial Fibrillation; Chronic Disease; Flecainide; | 2007 |
3 other studies available for flecainide and Equine Diseases
| Article | Year |
|---|---|
Treatment of recent-onset atrial fibrillation with quinidine and flecainide in Thoroughbred racehorses: 107 cases (1987-2014).
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Horse Diseases; Horses; Ma | 2018 |
Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Chronic D | 2004 |
Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardi | 2000 |